Effect of cholecalciferol supplementation on arterial stiffness: a systematic review and meta-analysis

Scandinavian Cardiovascular Journal

Volumn 50, Issue 4, 2016, Pages 230-235

  Upala, Sikarin ^a,b   Sanguankeo, Anawin ^a,b   Congrete, Soontharee ^c   Jaruvongvanich, Veeravich ^d  

^a Bassett Medical Center and Columbia University College of Physicians and Surgeons ^*  (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

Artery; Pulse wave velocity; Stiffness; Vitamin D; Vitamin supplementation

Indexed keywords

CALCIFEDIOL; CALCITRIOL; COLECALCIFEROL; PLACEBO; VITAMIN D; VITAMIN;

ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; VITAMIN SUPPLEMENTATION; CARDIOVASCULAR DISEASES; DRUG EFFECTS; PATHOPHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; CHOLECALCIFEROL; HUMANS; PULSE WAVE ANALYSIS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VITAMINS;

EID: 84969253443     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.3109/14017431.2016.1173226     Document Type: Article

References (29)

1. J.L.Anderson, H.T.May, B.D.Horne,. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963–968.
2. J.L.Vacek, S.R.Vanga, M.Good,. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2012;109:359–363.
3. H.Dobnig, S.Pilz, H.Scharnagl,. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168:1340–1349.
4. C.M.McEniery, S.Wallace, I.S.Mackenzie,. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006;48:602–608.
5. T.J.Anderson. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22:72B–80B.
6. I.Al Mheid, R.Patel, J.Murrow,. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58:186–192.
7. A.Levin. Kidneys, hearts, hormones and immunomodulators: integrated understandings. Blood Purif. 2006;24:46–50.
8. A.Breslavsky, J.Frand, Z.Matas,. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr. 2013;32:970–975.
9. Y.Dong, I.S.Stallmann-Jorgensen, N.K.Pollock,. A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J Clin Endocrinol Metab. 2010;95:4584–4591.
10. G.Dreyer, A.T.Tucker, S.M.Harwood,. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial. PLoS One 2014;9:e99461.
11. T.Larsen, F.H.Mose, J.N.Bech,. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens. 2012;25:1215–1222.
12. J.P.T.Higgins, S.Green, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Chichester; Hoboken, NJ: Wiley-Blackwell; 2008. p. 649.
13. S.Laurent, J.Cockcroft, L.Van Bortel,. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605.
14. G.Mancia, R.Fagard, K.Narkiewicz,. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357.
15. J.A.Sterne, M.Egger. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54:1046–1055.
16. G.Garg, G.Kachhawa, R.Ramot,. Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study. Endocr Connect. 2015;4:108–116.
17. F.H.Mose, H.Vase, T.Larsen,. Cardiovascular effects of cholecalciferol treatment in dialysis patients – a randomized controlled trial. BMC Nephrol. 2014;15:50.
18. S.Pilz, M.Gaksch, K.Kienreich,. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 2015;65:1195–1201.
19. M.D.Witham, F.Adams, S.McSwiggan,. Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome – a randomised controlled trial. Nutr Metab Cardiovasc Dis. 2015;25:287–294.
20. L.Wang, Y.Song, J.E.Manson,. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012;5:819–829.
21. R.Chowdhury, S.Stevens, H.Ward,. Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur J Epidemiol. 2012;27:581–591.
22. E.P.Carthy, W.Yamashita, A.Hsu,. 1,25-Dihydroxyvitamin D3 and rat vascular smooth muscle cell growth. Hypertension 1989;13:954–959.
23. G.Bjelakovic, L.L.Gluud, D.Nikolova,. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014;1:CD007470.
24. Q.Luo, L.L.Wang, Y.H.Gao. Association between serum 25-hydroxyvitamin D and arterial stiffness in non-dialysis-dependent CKD. Eur J Clin Nutr. 2016;70:274–276.
25. W.L.Jiang, H.B.Gu, Y.F.Zhang,. Vitamin D supplementation in the treatment of chronic heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol. 2016;39:56–61.
26. E.Patvardhan, K.S.Heffernan, J.Ruan,. Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factors. Cardiol Res Pract. 2011;2011:253758.
27. P.Lantelme, C.Mestre, M.Lievre,. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension 2002;39:1083–1087.
28. Y.Matsui, K.Kario, J.Ishikawa,. Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res. 2004;27:851–857.
29. E.M.van Leeuwen-Segarceanu, W.F.Tromp, W.J.Bos,. Comparison of two instruments measuring carotid-femoral pulse wave velocity: Vicorder versus SphygmoCor. J Hypertens. 2010;28:1687–1691.